NCT02669914: MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors |
|
|
| Terminated | 2 | 4 | US | MEDI4736, Durvalumab | Washington University School of Medicine, AstraZeneca | Non-Small Cell Lung Cancer, Nonsmall Cell Lung Cancer, Breast Cancer, Cancer of Breast, Cancer of the Breast, Gastroesophageal Cancer, Pancreatic Cancer, Cancer of the Pancreas, Colorectal Cancer, Colorectal Carcinoma, Renal Cancer, Kidney Cancer, Cancer of the Kidney, Cancer of Kidney, Ovarian Cancer, Ovary Cancer, Cancer of the Ovary, Cancer of Ovary | 09/17 | 01/18 | | |
